Biogen And Sangamo Announce Collaboration And $350 Million Deal

Biotech giants, Sangamo Therapeutics and Biogen, have announced a multi-million dollar partnership in the fight against Alzheimer's, Parkinson's, and other neurological diseases. Under the terms of the deal, Biogen will pay Sangamo $350 million as part of the collaboration on gene-regulation therapies. Sangamo is eligible for up to $2.37 billion in milestone payments...